Laddar...

Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients

This case report series describes 3 cases of cisatracurium besylate associated phlebitis after an infusion period of 14–20 hours. No similar cases have been reported in the literature. Association of phlebitis with another neuromuscular blocking agent, atracurium, has been described in the literatur...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:BMJ Case Rep
Huvudupphovsmän: Meeder, Annelijn M, van der Steen, Marijke S, Rozendaal, Annemieke, van Zanten, Arthur R H
Materialtyp: Artigo
Språk:Inglês
Publicerad: BMJ Publishing Group 2016
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5073701/
https://ncbi.nlm.nih.gov/pubmed/27698008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2016-216448
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!